Personalized gene and cell therapy for Duchenne Muscular Dystrophy

Neuromuscular Disorders : NMD
Florian Barthélémy, Nicolas Wein

Abstract

Dystrophinopathies are diseases caused by mutations in the Duchenne Muscular Dystrophy gene (DMD) encoding the dystrophin protein. Depending on the type of mutation, patients develop either the severe DMD or the milder Becker Muscular Dystrophy. Although substantial effort was made, the pathophysiology and variation in disease severity are still poorly understood. During the last two decades, relentless efforts were made to develop therapeutic strategies. Among these, gene therapy and cell replacement therapy appear very promising. These approaches are based on the replacement and/or repair of the mutated DMD gene or transcript at the molecular level, or at the cellular level via replacement of the damaged muscle cells. While highly successful in animal models, these therapies showed only modest efficacy in human clinical trials. More importantly, variable effects were observed in patients carrying the same mutation, suggesting that several factors (e.g., genetic modifiers, environmental factors) can affect treatment outcomes. In this review, we will describe recent advancements and new approaches of gene and cell therapies for dystrophinopathies that pave the way for a medicine "à la carte".

Citations

Jan 10, 2019·Journal of Personalized Medicine·Yuko Shimizu-MotohashiYoshitsugu Aoki
Nov 24, 2018·Protein Science : a Publication of the Protein Society·Dominique Mias-LucquinOlivier Delalande
Aug 15, 2019·Journal of the American Heart Association·Lee-Jae GuoChristopher F Spurney
Feb 1, 2020·Expert Opinion on Drug Discovery·Nalinda B WasalaDongsheng Duan
Feb 19, 2020·Expert Review of Proteomics·Paul DowlingKay Ohlendieck
Aug 21, 2020·Muscle & Nerve·Florian BarthelemyStanley F Nelson
Aug 9, 2019·Journal of Muscle Research and Cell Motility·Amber L Mueller, Robert J Bloch
Apr 10, 2019·Neural Regeneration Research·Simon Guiraud, Kay E Davies
Feb 26, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giuseppe VitaSonia Messina
Apr 17, 2019·Human Molecular Genetics·Simon GuiraudKay E Davies
Nov 7, 2019·Journal of Structural Biology·Dominique Mias-LucquinOlivier Delalande
Feb 11, 2021·European Journal of Human Genetics : EJHG·Vratko Himič, Kay E Davies
Mar 7, 2021·Journal of Clinical Medicine·Fernanda FortunatoAlessandra Ferlini
Nov 5, 2019·Molecular Therapy. Nucleic Acids·Florian BarthélémyM Carrie Miceli
May 4, 2021·Frontiers in Cell and Developmental Biology·Marisa CappellaMaria Grazia Biferi
Jun 25, 2020·Molecular Therapy. Methods & Clinical Development·Isabel PunzónStéphane Blot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.